Physician profile
Ashley P Read
NPI 1497138267
$4,764.22
in general payments reported to CMS, 2019-2025
14 companies · $2,236 in 2025
The $2,236 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $448 · 2022: $544 · 2023: $243 · 2024: $1,293 · 2025: $2,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,074 · Travel and Lodging: $1,069 · Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,073.98 |
| Travel and Lodging | $1,069.03 |
| Food and Beverage | $629.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,461.45 | 2022-2025 | Speedicath |
| Intuitive Surgical, INC. | $1,166.73 | 2024 | |
| Medtronic, INC. | $677.07 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $133.75 | 2021 | |
| Myovant Sciences INC. | $69.04 | 2021-2022 | |
| Abbvie INC. | $48.28 | 2023 | |
| 180 Medical, INC. | $47.83 | 2021-2023 | |
| Boston Scientific Corporation | $37.30 | 2022 | |
| Axonics, INC. | $34.79 | 2021-2023 | Bulkamid |
| Antares Pharma, INC. | $30.34 | 2021 | |
| Convatec INC. | $16.43 | 2021 | |
| Dentsply Ih INC. | $14.97 | 2021 | |
| Seqirus USA INC | $13.71 | 2021 | |
| Clarus Therapeutics INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Read listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.